Mirko Ljubo Lipovac

Dr. Mirko Ljubo Lipovac

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2025 in Cardiac Surgery and Interventional Cardiology
Verified
Journal Article
Open access
ABA. V. Biliavska
A. V. Biliavska
OZO. J. Zharinov
O. J. Zharinov
AMA. Yu. Melnyk
A. Yu. Melnyk
MLMirko Ljubo Lipovac
Mirko Ljubo Lipovac
YSYa. V. Skybchyk
Ya. V. Skybchyk
HKH. I. Kovtun
H. I. Kovtun
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically determined myocardial disease characterized by progressive replacement of cardiomyocytes with fibrofatty tissue, predominantly affecting the right ventricle. The condition is associated with malignant ventricular arrhythmias, heart failure, and a high risk of sudden cardiac death.Case Presentation. We present a 12‑year longitudinal follow‑up of a male patient diagnosed with ARVC, who underwent a full therapeutic pathway from antiarrhythmic drug therapy and implantable cardioverter‑defibrillator (ICD) implantation to orthotopic heart transplantation. Initially, the combination of amiodarone, beta‑blocker, and comprehensive quadruple heart failure therapy provided partial control of arrhythmic episodes. However, the disease progressed to biventricular failure accompanied by repeated ICD shocks despite optimal medical treatment.The patient was enrolled on the heart transplantation waiting list and subsequently underwent successful transplantation in 2024. The postoperative course was uneventful with stable graft function. The patient achieved complete structural and functional recovery of the transplanted myocardium under a standard triple immunosuppressive regimen including methylprednisolone, tacrolimus, and mycophenolate mofetil.Conclusions. This case highlights the progressive nature of ARVC and emphasizes the importance of early recognition of the disease, timely ICD implantation for prevention of sudden cardiac death, and heart transplantation as a life‑saving therapy in end‑stage disease. Individualized, multidisciplinary management remains essential for improving long‑term survival and quality of life in patients with ARVC.

29 January 2026 in Life
Verified
Journal Article
Open access
PDF file
APAna Peruničić
Ana Peruničić
SVStefan Veljković
Stefan Veljković
JLJovana Lakčević
Jovana Lakčević
MLMirko Ljubo Lipovac
Mirko Ljubo Lipovac
AŠArmin Šljivo
Armin Šljivo
ANAleksandra Nikolic
Aleksandra Nikolic
Background/Objectives. Ebstein’s anomaly (EA), which accounts for fewer than 1% of congenital heart diseases, and atrioventricular canal defect (AVCD), present in approximately 4–5% of cases, exceptionally coexist, with this combination observed in fewer than 0.5% of patients with AVCD. We aim to report the oldest documented case of a 45-year-old female with the exceptionally rare combination of complete AVCD, EA, and right ventricular hypoplasia and to provide a concise review of these anomalies. Case presentation. Diagnosed in early childhood with a complete AVCD, pulmonary stenosis, and right ventricular (RV) hypoplasia, the patient underwent palliative surgical intervention with a modified Blalock–Taussig shunt at the age of 10 but did not receive subsequent regular follow-up. Over the ensuing 35 years, she remained largely untreated until presentation at 45 years of age with progressive exertional dyspnea, central cyanosis, and palpitations, corresponding to NYHA class III. Comprehensive multimodal imaging, including transthoracic echocardiography and cardiac magnetic resonance, revealed a complete AVCD with moderate-to-severe mitral regurgitation secondary to an anterior mitral leaflet cleft, severe tricuspid regurgitation, RV hypoplasia, and hallmark features of EA. Given the complex cardiac anatomy and the elevated surgical risk, the patient was considered inoperable, and a strategy of conservative management with multidisciplinary follow-up was implemented. Conclusions. This case highlights the exceptional longevity of a patient with the rare coexistence of complete AVCD, EA, and RV hypoplasia, surviving 45 years from diagnosis despite limited early intervention. It underscores the importance of lifelong follow-up in complex congenital heart disease and illustrates the role of multimodal imaging in assessing anatomy and guiding management when surgical options are high-risk or not feasible.

3 December 2025 in Cardiac Surgery and Interventional Cardiology
Verified
Journal Article
Open access
YHYu. V. Hutsuliak
Yu. V. Hutsuliak
OZO. V. Zelenchuk
O. V. Zelenchuk
NYN. O. Yashchenko
N. O. Yashchenko
RMR. F. Mykytenko
R. F. Mykytenko
IKI. M. Kuzmich
I. M. Kuzmich
BTB. M. Todurov
B. M. Todurov
The aim – to evaluate the clinical outcomes of surgical treatment in patients with combined aortic and mitral valve disease in the setting of concomitant coronary artery disease (CAD), who underwent simultaneous valve replacement and coronary artery bypass grafting (CABG), with analysis of preoperative, intraoperative, and postoperative parameters. Materials and methods. A retrospective analysis of 35 cases of combined surgical interventions (AVR + MVR + CABG), performed at the Heart Institute of the Ministry of Health of Ukraine between 2019 and 2023, was conducted. The study assessed clinical characteristics, echocardiographic findings, intraoperative data, postoperative course, complications, and mortality rates. Risk stratification was performed using EuroSCORE II and the STS Risk Calculator.Results. In patients with severe multivalvular disease (n = 35), mitral regurgitation (100 %) and concomitant heart failure (94.3 %) were predominant. Postoperative improvement of NYHA class was observed in 74.3 % of cases. Mortality rate was 14.3 %, with infectious (51 %) and neurological (39 %) complications being common. Atrial fibrillation was associated with higher mortality. Postoperative echocardiography showed improved hemodynamics. These findings confirm the effectiveness of combined surgical intervention when careful patient selection is ensured.Conclusions. Simultaneous aortic and mitral valve replacement combined with coronary artery bypass grafting (CABG) represents a clinically justified surgical strategy for patients with combined valvular pathology and coronary artery disease, including those at intermediate and high risk according to the EuroSCORE II and STS scales. Despite acceptable survival rates, the incidence of postoperative complications remains significant, due to acute kidney injury, stroke, infections, ventricular fibrillation, and the need for reinterventions).

10 November 2026 in Life
Verified
Journal Article
Open access
PDF file
MLMirko Ljubo Lipovac
Mirko Ljubo Lipovac
JLJovana Lakčević
Jovana Lakčević
NANatalija Branko Arnautović
Natalija Branko Arnautović
BBBranislava Borzanović
Branislava Borzanović
Ivan Negovan BrzakovićIvan Negovan Brzaković
Ivan Negovan Brzaković
MBMilovan Bojic
Milovan Bojic
Primary cardiac synovial sarcoma is an exceptionally rare and aggressive malignancy in which complete surgical resection is often difficult. We report a 44-year-old man who presented in cardiogenic shock and underwent emergency resection of a right atrial tumor; histopathology confirmed high-grade biphasic synovial sarcoma with SS18 rearrangement. Early postoperative computed tomography showed a small residual component along the superior vena cava. Within two months, contrast-enhanced computed tomography demonstrated marked progression into the right atrium, with venous thrombosis, pulmonary embolism, pleural effusions and pericardial effusion. Transthoracic echocardiography subsequently showed a 60 × 38 mm right atrial mass causing hemodynamically significant functional tricuspid inflow obstruction, with a mean diastolic transtricuspid gradient of 8.7 mmHg averaged over five measurements at a mean heart rate of 129 beats/min. Echocardiography documented the functional significance of the intracardiac obstruction before urgent repeat surgery, whereas computed tomography defined its anatomical extent and associated extracardiac findings. Follow-up CT showed postoperative residual disease, and pulmonary nodules suspicious for metastatic spread were subsequently identified; the response to oncologic treatment could not be established from the available imaging. This case highlights the complementary anatomical and hemodynamic roles of computed tomography and echocardiography in rapid postoperative progression of primary cardiac synovial sarcoma.